Lung cancer Flashcards
Types of lung cancer?
- SCLC (15%) - smoking, early mets, more responsive to treatment
- NSCLC (85%) -
- squamous
- Adenocarcinoma = most common, best prognosis
- Large cell
- alveolar cell carcinoma
- Mesothelioma - pleural tumour, asbestos, no Tx
- Mets in lungs
History PC
Cough, haemoptysis, dyspnoea, chest pain, anorexia and weight loss
regional spread = dysphagia, hoarness - RLN
met = fatigue, low appetite, weight loss, paraneoplastic endocrone sx -(high Ca, cushings, SIADH)
diagnosis and relevant PMHx and SHx
Investigations: CXR, CT, bronchoscopy, sputum cytology needle biopsy, thoracotomy
PMHx - slow resolving Pnx, Pleural effusion, lung abscess, conditions that cause scarring (TB, scleroderma, ILD)
SHx - exposure (smoke, asbestos, radiation, toxic gasses)
Examination findings
General
- chachexia, fever, gynaecomastia, hoars voice
- cushingoid features (SCLC)
Peripheries/face
- clubbing (NSCLC)
- Hypertrophic pulmonary osteoarthropathy (HPOA) causing wrist pain
- Superclavicular/axillary nodes
- horners syndrome, SVC compression
Chest
inspection = dilated veins
palpation = boney pain
A/P = consolidation, collapse, P.Effusion
Neuro confusion (cortical degeneration), peripheral/autonomic neuropathy
Skin
DIC, migrating thrombophlebitis, acanthosis nigricans, purpura, scleroderma
signs of mets
= bone tenderness, hepatomegaly, focal neurology or confusion, cerebellar syndrome(ataxia, overshooting)
Complications of LC
local
- recurrent laryngeal nerve palsy
- phrenic nerve palsy
- SVC obstruction
- Horner’s syndrome
- Rib erosion
- pericarditis
- AF
Metastatic
- Brain, bone (>anaemia, inc Ca), Liver, Adrenals (>addison’s)
Endocrine
Ectopic hormone secretion
SCLC = SIADH and ACTH = low Na, high ADH, cushingoid
SSC = PTH = high Ca
Neuro
Eaton-lambert sundrome = proximal weakness + decreased reflexes
Confusion, fits, cerebellar syndrome
Other
Clubbing, HPOA, Dermatomyositis, Acanthosis nigricans, Thrombophelbitis migranes
Ix for diagnosis
Cytology
- sputum if centeral
- pleural fluid if effusion
CXR
Adenocarcinoma = peripheral node
SCLC = hilar enlargement
Consolidation, collapse, pleural effusion, bony secondaries
Bronchoscopy
biopsy/FNA
Assess operability
Ix for staging and Ix for treatment
STAGING
bloods - FBC, Ca, LFTs, ACTH, ADH, Na
imaging - CT, PET, +/- bone scan
TX
Lung function tests
FEV1 > 1.5L could tolerate pneumonectomy
Can climb 3 flights is positive predictor
Management NSCLC and prognosis
excision if localised and no mets (1/3 of cases)
Curative radiotherapy
Chemo + radiotherapy if more advanced
50% at 2 years if no spread
10% at 2 years if spread
Management SCLC and prognosis
Immunotherapy
Chemotherapy with platinum based drugs
cranial irratiation
…paliation
median survival 3/12 without treatment
8-13/12 with < 5% at 2 years with treatment